Long-acting injectable form of HIV prevention outperforms daily pill in NIH study

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).


07/07/2020 09:00 AM EDT

Both methods highly effective at preventing HIV among men who have sex with men and transgender women.